Currently, there are 730.80M common shares owned by the public and among those 612.31M shares have been available to trade.
Insiders at the company have transacted a total of 120 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 99 of these insider trades were purchases, accounting for 743,275 shares. Insider sales of the common stock occurred on 21 occasions, with total insider shares sold totaling 376,497 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
However, the script later moved the day high at 68.71, down -1.04%. The company’s stock has a 5-day price change of 2.85% and 12.15% over the past three months. MET shares are trading 2.59% year to date (YTD), with the 12-month market performance down to -4.99% lower. It has a 12-month low price of $48.95 and touched a high of $73.12 over the same period. MET has an average intraday trading volume of 1.30 shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -0.64%, 1.19%, and 10.56% respectively.
Institutional ownership of Metlife Inc (NYSE: MET) shares accounts for 75.59% of the company’s 730.80M shares outstanding.
It has a market capitalization of $49.58B and a beta (3y monthly) value of 1.04. The stock’s trailing 12-month PE ratio is 37.08, while the earnings-per-share (ttm) stands at $1.83. The company has a PEG of 3.22 and the debt-to-equity ratio at 0.76. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.02% over the week and 1.76% over the month.
Earnings per share for the fiscal year are expected to increase by 21.89%, and 12.71% over the next financial year. EPS should grow at an annualized rate of 11.50% over the next five years, compared to -18.10% over the past 5-year period.
Looking at the support for the MET, a number of firms have released research notes about the stock. Goldman stated their Buy rating for the stock in a research note on January 08, 2024, with the firm’s price target at $80.
